Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Molecular Analysis Of Bladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00871754
Recruitment Status : Active, not recruiting
First Posted : March 30, 2009
Last Update Posted : January 19, 2022
Information provided by (Responsible Party):
Linda Topjian, Lahey Clinic

Brief Summary:
This is a laboratory study where the investigators hope to look at chromosomal events implicated in bladder cancer.

Condition or disease
Bladder Cancer Bladder Neoplasms

Layout table for study information
Study Type : Observational
Estimated Enrollment : 5000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Molecular Analysis Of Bladder Cancer
Study Start Date : April 1988
Estimated Primary Completion Date : December 2025
Estimated Study Completion Date : December 2025

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bladder Cancer

Biospecimen Retention:   Samples With DNA

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patient's undergoing removal of a malignant bladder tumor

Inclusion Criteria:

  • Bladder cancer

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00871754

Layout table for location information
United States, Massachusetts
Lahey Clinic
Burlington, Massachusetts, United States, 01805
Sponsors and Collaborators
Lahey Clinic
Layout table for investigator information
Principal Investigator: Kim Reiger-Christ, PhD Lahey Clinic
Layout table for additonal information
Responsible Party: Linda Topjian, study coordinator, Lahey Clinic Identifier: NCT00871754    
Other Study ID Numbers: 88-009A
First Posted: March 30, 2009    Key Record Dates
Last Update Posted: January 19, 2022
Last Verified: January 2022
Keywords provided by Linda Topjian, Lahey Clinic:
Bladder Cancer
Cancer, bladder
Urinary Bladder Cancer
Additional relevant MeSH terms:
Layout table for MeSH terms
Urinary Bladder Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Urinary Bladder Diseases
Urologic Diseases